CTLA4 and metastatic melanoma: We found that the non- or reversed association was reproduced in two other cohorts (metastatic melanoma with anti-CTLA4 treatment, N = 26 and with anti-PD1 treatment, N = 39) (Fig. 1d and 1e), confirming the weak or no relationship of HLA allelic copy number states and ICB response.